Connect with us

News

India Likely To Have COVID Vaccine For Children Above 2 Years By September-October: AIIMS Director

Children usually have the mild disease but we need to develop vaccines for children because if we have to control this pandemic everyone should be vaccinated, says AIIMS Director Dr Randeep Guleria

Hopefully, by September-October, we’ll have vaccines from our country which we can give to children: Dr Guleria
Highlights
  • Covaxin data for children after completion of trials expected by September
  • Covaxin is an indigenous vaccine developed by Bharat Biotech & ICMR
  • Bharat Biotech conducting trials between the age of 2 to 18 years

New Delhi: Noting that children usually have a mild disease but there is a need to develop COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will lead to approvals so that there is a vaccine for children in the country by September-October. In an interview with ANI, Dr Guleria said that Covaxin’s data for children after completion of phase two or three trials is expected by September-October.

Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with ICMR.

Children usually have the mild disease but we need to develop vaccines for children because if we have to control this pandemic everyone should be vaccinated. Bharat Biotech and other companies are doing trials at a very fast pace as parents have come forward with their children for the trials, he said.

Also Read: Vaccination Needs To Be Boosted Massively As The Contagious Delta Variant Of COVID-19 Continues To Spread, Says Epidemiologist Dr Eric Feigl-Ding

One is hopeful that trial will be completed early and possibly with follow up of about two-three months, we shall have data by September. Hopefully, by that time, approvals will be there so that by September-October, we’ll have vaccines from our country which we can give to children, he added.

Dr Guleria said Bharat Biotech is conducting trials between the age group of 2 to 18 years and “this covers a wide spectrum”.

Asked about Zydus Cadila vaccine, he said it is a DNA vaccine, a new platform is being used and “it is something that we should proud of”.

He added that it is a platform for which research has not been done in past in the country.

The data is still being collated and one is hoping that they will be able to submit the data to the DCGI for regulatory approval. It will depend on the company how quickly it is able to collate the data and give it to the regulatory authority, he said.

Asked about Pfizer CEO stating that the company is in the “final stages” of getting approval for its COVID-19 vaccine in India, Dr Guleria said that the firm has been in negotiations for some time and these would have possibly reached the final stage.

One is hopeful that it should occur because the negotiations with the company is going on for quite some time. I am sure now they are reaching a stage where final sort understanding will be there, he said.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Highlights Of The 12-Hour Telethon

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पड़े

Folk Music For A Swasth India

RajasthanDay” src=